Complement Levels and Risk of Organ Involvement in Patients with Systemic Lupus Erythematosus

Evaluation of Serum Complement C3 and C4 Levels as biomarkers for Systemic Lupus Erythromatosus

Study of Some Biomarkers Changes in Patients with Lupus Nephritis and Their Correlation with Disease Activity and Progression

Serum and Circulatory Omentin mRNA Gene Expression as Predictive Markers of Systemic Lupus Erythematosus Disease Activity and Lupus Nephritis

Anti-C1q antibodies as a marker for disease activity in systemic lupus erythematosus and lupus nephritis

Urinary Soluble CD163 Levels as a Biomarker for Activity of Systemic Lupus Erythematosus

Soluble CD163 as a biomarker for renal involvment in systemic lupus erythematosus patients

Antibodies against monomeric C-reactive protein as a promising biomarker of lupus nephritis

Correlation of Serum Neopterin level with Complement C3, C4 in assessment of Systemic Lupus Erythematosus Activity

Interleukin 17 role as a biomarker in Systemic Lupus Erythematosus patients.